Metraipolis › archive › dc_71ccf468bc07

Orelabrutinib in combination with pomalidomide for the successful treatment of primary vitreoretinal lymphoma: a case report — Europe PMC PMID:42630247

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42630247
DOI: 10.3389/fmed.2026.1806373
License (as archived): solo-consultazione
Archived: 2026-10-16T23:56:19.007Z
SHA-256 of the archived text: 1efc2f21fc5d28c85876ba5fb92c4375b57eb9617fc7c5d70de77ba2ea6b1dbc
Stable URL of this page: https://metraipolis.com/documento/dc_71ccf468bc07

How to cite

Orelabrutinib in combination with pomalidomide for the successful treatment of primary vitreoretinal lymphoma: a case report — Europe PMC PMID:42630247 — Europe PMC (en), https://europepmc.org/article/MED/42630247 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71ccf468bc07 (Metraipolis archive dc_71ccf468bc07, sha256 1efc2f21fc5d28c85876ba5fb92c4375b57eb9617fc7c5d70de77ba2ea6b1dbc)

BibTeX

@misc{dc71ccf468bc07,
  title = {Orelabrutinib in combination with pomalidomide for the successful treatment of primary vitreoretinal lymphoma: a case report — Europe PMC PMID:42630247},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42630247},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71ccf468bc07; sha256 1efc2f21fc5d28c85876ba5fb92c4375b57eb9617fc7c5d70de77ba2ea6b1dbc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630247. Agents can read the archived copy with the MCP tool read_document.